Iovance Biotherapeutics (IOVA) Earnings Date & Reports

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IOVA is expected to report earnings to rise 12.91% to -12 cents per share on November 05

Iovance Biotherapeutics IOVA Stock Earnings Reports

Q3'26

Est.

$-0.12

Q2'26

Beat

by $0.02

Q1'26

Missed

by $0.05

Q4'25

Missed

by $0.01

Q3'25

Beat

by $0.01

The last earnings report on August 06 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 10.97M shares outstanding, the current market capitalization sits at 2.96B.

View a ticker or compare two or three

IOVA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days